Stay updated on A(B)VD+Nivolumab in Frontline for HL Clinical Trial

Sign up to get notified when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Glossary toggle added and metadata expanded with additional MeSH terms and related keywords (e.g., Nivolumab, Doxorubicin, Vinblastine, Bleomycin, Dacarbazine). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    63%
    Check dated 2026-01-28T00:43:41.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision label Revision: v3.3.4 was added, replacing Revision: v3.3.3. This appears to be a minor site maintenance update and does not affect study information.
    Difference
    0.0%
    Check dated 2026-01-14T00:32:17.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Locations sections for Michigan, New Jersey, and New York have been added, and the previous separate location blocks for these states have been removed. This update corresponds to revision v3.3.3 of the page.
    Difference
    0.4%
    Check dated 2025-12-23T08:31:31.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 in the page footer.
    Difference
    0.0%
    Check dated 2025-12-01T16:28:23.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate PubMed-sourced items are automatically filled. The page now shows a Last Update Posted (Estimated) date and a Revision: v3.3.1.
    Difference
    0.3%
    Check dated 2025-11-24T11:07:08.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The notice about government funding and NIH operating status has been removed. This does not affect the study details, eligibility criteria, or outcomes listed for NCT03033914.
    Difference
    0.3%
    Check dated 2025-11-17T06:12:12.000Z thumbnail image

Stay in the know with updates to A(B)VD+Nivolumab in Frontline for HL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A(B)VD+Nivolumab in Frontline for HL Clinical Trial page.